Trial Information

Summary: Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents with Bipolar Disorder

Dr. Gagan Joshi is conducting a research study at the MGH Pediatric Psychopharmacology Research Unit for children and adolescents with Bipolar Disorder and Obsessive-Compulsive Disorder (OCD). The study is designed to use fluoxetine to treat OCD symptoms for subjects who are adequately mood stabilized on a regimen based on standard clinical care. Subjects may enter the study if their mood symptoms are adequately stabilized and they continue to experience OCD symptoms. All participating subjects will receive the study medication – Fluoxetine (study does not involve placebo, which looks like study drug but contains no active medication). Subjects will continue on their mood medication during the study period. The study would involve weekly visits with a maximum of 14 weeks commitment.

Eligibility Criteria:
We are looking for male and female subjects 6-17 years of age. Subjects may enter the study if their mood symptoms are adequately stabilized and they continue to experience OCD symptoms.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.